|
966
|
| 6099 |
Phosphatidylinositol 3-kinase (PIK3CA, PIK3R1)
|
|
increases_quantity of
|
XIAP
|
|
| 6103 |
AKT1
|
|
increases_quantity of
|
XIAP
|
|
|
15339911
|
Amyotrophic lateral sclerosis
|
|
975
|
| 5994 |
response to endoplasmic reticulum stress
|
|
increases_expression of
|
XIAP
|
|
| 5996 |
XIAP
|
|
decreases_activity of
|
cell death
|
|
|
15339911
|
Amyotrophic lateral sclerosis
|
|
2,989
|
| 27277 |
response to nitric oxide
|
|
decreases_activity of
|
XIAP
|
|
| 27318 |
XIAP
|
|
decreases_activity of
|
cysteine-type endopeptidase activity involved in apoptotic process
|
|
|
21902456
|
Alzheimer disease
|
|
2,999
|
| 27297 |
Protein kinase C
|
|
increases_activity of
|
XIAP
|
|
| 27312 |
Protein kinase C
|
|
increases_phosphorylation of
|
XIAP
|
at Ser87
|
| 27317 |
12-O-Tetradecanoylphorbol 13-acetate
|
|
increases_phosphorylation of
|
XIAP
|
at Ser87
|
|
21707856
|
Alzheimer disease
|
|
6,871
|
| 67127 |
Tos-Phe-CH2Cl
|
|
increases_processing of
|
XIAP
|
|
|
19679660
|
Neutropenia, severe congenital, 3
|
|
6,908
|
| 67577 |
XIAP
|
|
affects_activity of
|
Inflammatory bowel disease 1
|
|
| 67579 |
XIAP
|
|
affects_activity of
|
Lymphoproliferative syndrome, X-linked 2
|
|
| 67581 |
XIAP
|
|
affects_activity of
|
NOD signaling
|
|
|
|
Inflammatory bowel disease 1
Inflammatory bowel disease
|
|
7,042
|
| 68907 |
TRIM32
|
|
interacts (colocalizes) with
|
XIAP
|
|
| 68925 |
TRIM32
|
|
decreases_quantity of
|
XIAP
|
via ubiquitination and proteasome-dependent degradation
|
| 68936 |
TRIM32
|
|
increases_ubiquitination/sumoylation of
|
XIAP
|
|
|
21628460
|
Inflammation
|
|
7,047
|
| 69128 |
XIAP
|
|
affects_activity of
|
Inflammatory bowel disease
|
|
|
|
Inflammatory bowel disease
|
|
7,048
|
| 69129 |
XIAP
|
|
interacts (colocalizes) with
|
RIPK2
|
in HEK293T cells and THP-1 monocytes
|
|
|
Inflammation
|
|
7,049
|
| 69189 |
XIAP
|
|
interacts (colocalizes) with
|
RIPK2
|
|
| 69191 |
XIAP
|
|
increases_ubiquitination/sumoylation of
|
RIPK2
|
in THP-1 cells
|
| 69196 |
XIAP
|
|
increases_activity of
|
LUBAC complex
|
in HCT-116 cells
|
| 69293 |
XIAP
|
|
affects_activity of
|
X-linked lymphoproliferative syndrome-2
|
|
| 69294 |
XIAP
|
|
affects_activity of
|
Inflammatory bowel disease
|
|
|
|
Inflammatory bowel disease
Inflammation
|
|
7,055
|
| 69433 |
SIVA1
|
|
interacts (colocalizes) with
|
XIAP
|
in HeLa cells and in Jurkat T cells
|
| 69532 |
XIAP
|
|
increases_ubiquitination/sumoylation of
|
SIVA1
|
in Jurkat T cells
|
| 69533 |
XIAP
|
|
decreases_activity of
|
SIVA1
|
in Jurkat T cells ; via K48-linked ubiquitylation
|
| 69534 |
XIAP
|
|
decreases_activity of
|
apoptotic process
|
in Jurkat T cells ; induced by SIVA1
|
| 69550 |
XIAP
|
|
decreases_activity of
|
CASP3
|
|
|
|
Metabolic
|
|
7,057
|
| 69424 |
XIAP
|
|
interacts (colocalizes) with
|
TAB1
|
|
| 69425 |
XIAP
|
|
interacts (colocalizes) with
|
BMPR1A
|
|
|
|
Metabolic
|
|
7,077
|
| 69584 |
HAX1
|
|
decreases_ubiquitination/sumoylation of
|
XIAP
|
shown in HEK 293T cells
|
| 69587 |
XIAP
|
|
is_part_of
|
HAX-1-XIAP complex
|
shown in HEK 293T cells and Bosc 23 cells
|
|
|
Metabolic
|
|
8,974
|
| 93764 |
NF-kappaB complex
|
|
affects_expression of
|
XIAP
|
mediating anti-apoptotic effects
|
| 93766 |
Proline
|
|
increases_expression of
|
XIAP
|
received proline
orally before GalN administration, with a decline after the peak at 24 h
|
| 93768 |
XIAP
|
|
increases_activity of
|
negative regulation of apoptotic process
|
|
|
22585093
|
Metabolic
Inflammation
|
|
10,212
|
| 106212 |
HTRA4
|
|
interacts (colocalizes) with
|
XIAP
|
|
|
31470122
|
Cancer
Preeclampsia
|
|
10,213
|
| 106219 |
HTRA4
|
|
interacts (colocalizes) with
|
XIAP
|
|
| 106221 |
HTRA2
|
|
interacts (colocalizes) with
|
XIAP
|
|
|
31036715
|
Cancer
Preeclampsia
|
|
13,474
|
| 127025 |
NF-kappaB complex
|
|
increases_expression of
|
XIAP
|
|
|
25474138
|
Hepatocellular carcinoma
Cancer
|
|
16,197
|
| 156604 |
BMP2
|
|
interacts (colocalizes) with
|
XIAP
|
|
|
|
Metabolic
|
|
16,198
|
| 156605 |
XIAP
|
|
interacts (colocalizes) with
|
PRDX2
|
|
|
|
Metabolic
|
CIDeRplus